Aeglea Bio Therapeutics Price on December 12, 2024
AGLEDelisted Stock | USD 0.59 0.01 1.72% |
If you're considering investing in Aeglea Stock, it is important to understand the factors that can impact its price. As of today, the current price of Aeglea Bio stands at 0.59, as last reported on the 13th of December 2024, with the highest price reaching 0.62 and the lowest price hitting 0.58 during the day. We have found twenty-nine technical indicators for Aeglea Bio Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Aeglea Bio's risk adjusted performance of 0.098, and Mean Deviation of 11.03 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Aeglea Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Aeglea |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
AGLE |
Based on monthly moving average Aeglea Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aeglea Bio by adding Aeglea Bio to a well-diversified portfolio.
Related Headline
SAB Biotherapeutics Headline on 12th of December 2024
SAB Biotherapeutics, Inc. Short Interest Update by thelincolnianonline.com
SAB Biotherapeutics, Inc. saw a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 4,300 shares, a growth of 72.0 percent from the November 15th total of 2,500 shares. Based on an average daily volume of 16,900 shares, the days-to-cover ratio
Aeglea Bio Valuation on December 12, 2024
It is possible to determine the worth of Aeglea Bio on a given historical date. On December 12, 2024 Aeglea was worth 0.58 at the beginning of the trading date compared to the closed value of 0.59. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Aeglea Bio stock. Still, in general, we apply an absolute valuation method to find Aeglea Bio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aeglea Bio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Aeglea Bio's related companies.
Open | High | Low | Close | Volume | |
12/13/2024 | 0.58 | 0.62 | 0.58 | 0.59 | 0.00 |
Backtest Aeglea Bio | | | Aeglea Bio History | | | Aeglea Bio Valuation |
Aeglea Bio Trading Date Momentum on December 12, 2024
Aeglea Bio Therapeutics Fundamentals Correlations and Trends
By evaluating Aeglea Bio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Aeglea Bio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Aeglea financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Aeglea Bio Stock history
Aeglea Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aeglea is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aeglea Bio Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aeglea Bio stock prices may prove useful in developing a viable investing in Aeglea Bio
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. Aeglea BioTherapeutics, Inc. was founded in 2013 and is headquartered in Austin, Texas. Aeglea Biothera operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 69 people.
Aeglea Bio Stock Technical Analysis
Aeglea Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Aeglea Bio Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
Aeglea Bio Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Aeglea Bio December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how Aeglea Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aeglea Bio shares will generate the highest return on investment. By undertsting and applying Aeglea Bio stock market strength indicators, traders can identify Aeglea Bio Therapeutics entry and exit signals to maximize returns
Aeglea Bio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aeglea Bio's price direction in advance. Along with the technical and fundamental analysis of Aeglea Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aeglea to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.098 | |||
Jensen Alpha | 4.69 | |||
Total Risk Alpha | (0.75) | |||
Sortino Ratio | 0.5417 | |||
Treynor Ratio | 4.26 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Aeglea Stock
If you are still planning to invest in Aeglea Bio Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aeglea Bio's history and understand the potential risks before investing.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |